Discovery accesses a deep reservoir of specimens, facilities, technologies, and expertise to equip our researcher clients with large-scale, custom services in oncogene testing, sequencing, and ancillary genomic services.
For more details about our genomic services, please begin a consultation with your business development manager or submit the form below.
Discovery's genomic services identify relevant biomarkers in both cell and tissue samples, including blood, cell isolations, tissue dissociations, and FFPE. These services are designed to produce high-quality data. For example, our sequencing standards default to high-read depths unless lower read depths are specifically requested.
The benefits of sourcing and genomically characterizing biospecimens from a single vendor partner include: